pharma · Infertility · Ovarian Cancer · NWBO
NORTHWEST BIOTHERAPEUTICS
NORTHWEST BIOTHERAPEUTICS INC
NORTHWEST BIOTHERAPEUTICS is a pharma organization headquartered in Bethesda, USA. It trades on NYSE under ticker NWBO. Primary therapeutic focus areas include Infertility, Ovarian Cancer, Environmental Exposure, Colorec
4800 Montgomery Lane, Suite 800, Bethesda, MD 28014, US HQ
1998 Founded
20 Employees
Public company Type
NWBO · NYSE Ticker
Company details
- Status
- Public
- HQ
- 4800 Montgomery Lane, Suite 800, Bethesda, MD 28014, US
- Founded
- 1998
- Employees
- 20
- Programs
- 33
- Drugs
- 40
- Patents
- 595
[14C]-benzo[a]pyrene
Phase 1 · small molecule · Environmental Exposure
[14C]-benzo[a]pyrene for Environmental Exposure is a Phase 1 program (small_molecule) at NORTHWEST BIOTHERAPEUTICS INC with 3 ClinicalTrials.gov record(s).
Internal code LPI-8233
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- NORTHWEST BIOTHERAPEUTICS INC
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Environmental Exposure
- Status
- completed
- Trials
- 3